SummerHaven Investment Management’s Fulgent Genetics FLGT Stock Holding History

SummerHaven Investment Management’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,074	Closed	-$373K	–	225
2023 Q2	$373K	Sell	10,074 -4,050	-29%	-$141K	0.24%	180
2023 Q1	$441K	Buy	14,124 +543	+4%	+$17.5K	0.26%	188
2022 Q4	$404K	Buy	13,581 +304	+2%	+$10.9K	0.24%	198
2022 Q3	$506K	Buy	13,277 +1,861	+16%	+$93.3K	0.35%	194
2022 Q2	$623K	Hold	11,416	–	–	0.42%	133
2022 Q1	$712K	Buy	11,416 +506	+5%	+$33.3K	0.4%	152
2021 Q4	$1.1M	Hold	10,910	–	–	0.59%	39
2021 Q3	$981K	Buy	+10,910	New	+$992K	0.57%	26

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SummerHaven Investment Management's FLGT Position: Q3 2023 in Review

SummerHaven Investment Management sold out of Fulgent Genetics (FLGT) in Q3 2023, closing a stake of 10,074 shares — an estimated $373K sold.

SummerHaven Investment Management first reported a position in FLGT in Q3 2021 and held it in 8 quarters. The position peaked at $1.1M in Q4 2021. 201 funds tracked by Wall St. Rank hold FLGT as of Q3 2023.

SummerHaven Investment Management reported no remaining Fulgent Genetics position as of Q3 2023 after selling out during the quarter.
SummerHaven Investment Management sold 10,074 Fulgent Genetics shares in Q3 2023, an estimated $373K.
SummerHaven Investment Management first reported a position in Fulgent Genetics in Q3 2021 and held it in 8 quarters.
SummerHaven Investment Management's Fulgent Genetics position peaked at $1.1M in Q4 2021.
201 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2023.

Based on SummerHaven Investment Management's 13F filing for Q3 2023, filed 13 Oct 2023.